Physician profile
Denise A Rodda
NPI 1295576858
$1,419.82
in general payments reported to CMS, 2019-2025
16 companies · $1,420 in 2025
The $1,420 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,419.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $347.97 | 2025 | Breztri, Tezspire, Airsupra |
| Actelion Pharmaceuticals US, INC. | $203.35 | 2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.26 | 2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $107.01 | 2025 | Nucala, Trelegy Ellipta |
| Baxter Healthcare | $104.70 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Amgen INC. | $75.17 | 2025 | Tezspire |
| Viatris Specialty LLC | $64.96 | 2025 | Yupelri |
| Insmed, INC. | $51.89 | 2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $51.77 | 2025 | Glassia |
| Mallinckrodt Hospital Products INC. | $45.57 | 2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $42.85 | 2025 | Dupixent |
| Electromed, INC. | $42.27 | 2025 | Smartvest |
| Vifor Pharma, INC. | $39.69 | 2025 | Zemaira |
| Inogen, INC. | $35.77 | 2025 | |
| Genzyme Corporation | $18.81 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $15.78 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Rodda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.